Biotech · Private company · Washington, DC, US
VitaKey Inc.
Track this companyFree. Adds VitaKey Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- ControlNutritionClinicalTrials.gov · fetched Nov 12, 2026
- Extended release nutritional proteinNutritionClinicalTrials.gov · fetched Nov 12, 2026
- Negative DoseNutritionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Extended Release Protein DosingNA · ACTIVE_NOT_RECRUITING · started Nov 17, 2025ClinicalTrials.gov NCT07313436 · fetched Nov 12, 2026
NIH awards4
- Stabilization of therapeutic microbes for inclusion in a liquid matrix for delivery to the intestinesFiscal year 2026 · $607.9KNIH RePORTER 5R44GM146506-03 · fetched Nov 12, 2026
- Platform technology for delivery of stabilized therapeutic microbes in powders with high water activityFiscal year 2025 · $349.8KNIH RePORTER 1R43HD117653-01 · fetched Nov 12, 2026
- Stabilization of therapeutic microbes for inclusion in a liquid matrix for delivery to the intestinesFiscal year 2025 · $1.4MNIH RePORTER 2R44GM146506-02 · fetched Nov 12, 2026
- Platform technology for targeted delivery of proteins to the intestinesFiscal year 2024 · $349KNIH RePORTER 1R43DK140050-01 · fetched Nov 12, 2026